Suchergebnisse - "Dofferhoff, A S M"

PubPharm (38)

1

Hepatitis C Elimination in the Netherlands (CELINE) : How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

enthalten in: European journal of internal medicine | 2022

von Isfordink, C. | van Dijk, M. | Brakenhoff, S. | +52

2

Serious side effects of fluoroquinolones : low risk of connective tissue-related disorders such as aneurysms

enthalten in: Nederlands tijdschrift voor geneeskunde | 2020

von Boes, J. | Dofferhoff, A. | Fleuren, H. | +1

3

Diagnostic algorithm for COVID-19 at the ER

enthalten in: Nederlands tijdschrift voor geneeskunde | 2020

von Dofferhoff, A. | Swinkels, A. | Sprong, T. | +7

4

Nieuwe behandelingsmethoden voor hepatitis B en C

enthalten in: Bijblijven | 2018

von Dofferhoff, A.

5

Nieuwe behandelingsmethoden voor hepatitis B en C

enthalten in: Bijblijven | 2018

von Dofferhoff, A.

6

Nieuwe behandelingsmethoden voor hepatitis B en C

enthalten in: Bijblijven | 2018

von Dofferhoff, A.

7

Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals

enthalten in: Alimentary pharmacology & therapeutics | 2017

von van Tilborg, M. | Lieveld, F. | Smolders, E. | +12

CommentIn: Aliment Pharmacol Ther. 2017 Dec;46(11-12):1115-1116. - PMID 29105131

8

Ribavirin steady‐state plasma level is a predictor of sustained virological response in hepatitis C–infected patients treated with direct‐acting antivirals

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Tilborg, M. | Lieveld, F. | Smolders, E. | +11

9

Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort

enthalten in: HIV medicine | 2016

von Rokx, C. | Gras, L. | van de Vijver, D. | +103

10

Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment‐naïve HIV‐1‐infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort

enthalten in: HIV medicine | 2016

von Rokx, C. | Gras, L. | Vijver, D. | +98